Tarsier Pharma
Clinical-stage company developing novel treatments for ocular inflammatory blinding diseases.
About
Technology stack
detected 2026-06-12No comments yet. Be the first to share your take.
What does Tarsier Pharma do?
Tarsier Pharma is a late clinical-stage company developing bio-inspired medical solutions for autoimmune and inflammatory ocular diseases. Their breakthrough platform technology, Dazdotuftide (TRS), aims to re-engineer the immune system to treat conditions like uveitis, with a pipeline including eye drops and intravitreal injections. They serve patients suffering from blinding ocular diseases and provide information for healthcare providers and investors.
How much funding has Tarsier Pharma raised?
Tarsier Pharma has raised a total of $5M in funding. The most recent round on record is Series B.
Where is Tarsier Pharma headquartered?
Tarsier Pharma is headquartered in Tel Aviv, Israel.
When was Tarsier Pharma founded?
Tarsier Pharma was founded in 2016.
What industry does Tarsier Pharma operate in?
Tarsier Pharma operates in Healthcare, Disease Treatment, Vision Impairment, Biotech, MedTech, HealthTech.
How many employees does Tarsier Pharma have?
Tarsier Pharma has approximately 12 people on record.